Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months

By Larry Ramer, InvestorPlace Contributor
Recent, positive clinical data released by Novavax (NVAX) indicates that NVAX stock could surge almost 12 times in the next year.

Why Is Novavax (NVAX) Stock Moving Today?

By William White, InvestorPlace Writer
Novavax (NVAX) stock is on the move Wednesday despite a lack of news from the vaccine company and no heavy trading volume.

Why Is PLx Pharma (PLXP) Stock Down 32% Today?

By William White, InvestorPlace Writer
PLx Pharma (PLXP) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange.

Why Is Altamira Therapeutics (CYTO) Stock Up 64% Today?

By William White, InvestorPlace Writer
Altamira Therapeutics (CYTO) stock is taking off on Wednesday after providing an update on its SemaPhore nanoparticle technology.

Why Design Therapeutics (DSGN) Stock Is Going Nowhere But Down

By David Moadel, InvestorPlace Contributor
Design Therapeutics has multiple research programs and a strong drive to combat genetic disorders, but that's not enough to save DSGN stock.

3 Biotech Stocks to Watch for Potential Breakthroughs

By Alex Sirois, InvestorPlace Contributor
These biotech stocks have significant upside and realistic breakthrough chances in the current and distant future.

Why Is PLx Pharma (PLXP) Stock Down 38% Today?

By William White, InvestorPlace Writer
PLx Pharma (PLXP) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall.

HEXO Stock Alert: Tilray to Acquire Hexo in $56 Million Deal

By Dana Blankenhorn, InvestorPlace Contributor
The cannabis industry continues to consolidate, and Tilray, its second-largest player, is now heavily engaged in craft beer.

Why Is Clearmind Medicine (CMND) Stock Up 56% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is taking off on Tuesday with heavy trading despite a lack of news concerning the psychedelics company.

3 Penny Stocks to Add to Your Watchlist for Potential Breakouts

By Noah Bolton, InvestorPlace Contributor
These penny stocks are catching the attention of big-money investors as they continue to build up momentum for a potential breakout.

3 Overvalued Blue-Chip Stocks Not Worth Your Green

By Faizan Farooque, InvestorPlace Contributor
Overvalued blue-chip stocks are the ones to avoid right now, as the markets continue to figure out where the economy is headed next.

7 Penny Stocks to Keep an Eye on for the Rest of the Year

By Muslim Farooque, InvestorPlace Contributor
These penny stocks to watch have dropped significantly in value in 2022, but are poised for a robust pullback this year

3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth

By John Blankenhorn, InvestorPlace Contributor
Medical device stocks are set to rise with an aging population and continued improvements in technology. Here are 3 stocks to watch.

7 Biotech Stocks to Buy for 100% Returns

By Josh Enomoto, InvestorPlace Contributor
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.

The 3 Best Millionaire-Maker Stocks to Buy for April 2023

By Larry Ramer, InvestorPlace Contributor
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. 

7 A-Rated Stocks to Buy for April 2023

By Louis Navellier and the InvestorPlace Research Staff
Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape.

The 3 Most Promising Penny Stocks to Buy in April

By Chris Markoch, InvestorPlace Contributor
Here are three of the most promising penny stocks from some of the most popular growth sectors emerging in 2023

Is Pfizer Stock a Buy, Sell or Hold? Here’s My Call.

By David Moadel, InvestorPlace Contributor
Pfizer can't depend on Covid-19 vaccines as a revenue source in 2023, but PFE stock can still grow as the drugmaker broadens its pipeline.

The 3 Best Bargain Stocks to Buy for April 2023

By Bret Kenwell, InvestorPlace Contributor
Despite a solid rally in the first quarter of 2023, there are plenty of bargain stocks left for long-term investors, and here are three.
Load More Articles